{"disease":{"id":"socket-type-3-subclass-c","name":"socket type 3 subclass c"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07533110","title":"Evaluation Of The Success Rate of NOVAMag® SHIELD In Two Different Advanced Bone Defects: A Randomized Controlled Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Egas Moniz - Cooperativa de Ensino Superior, CRL","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}